Vital Signs buys fluid warming company:
This article was originally published in Clinica
Executive Summary
Anaesthesia breathing systems manufacturer Vital Signs has bought blood warming technology specialist Enginivity in a deal worth $5.9m. The deal sees Totowa, New Jersey-based Vital Signs acquire the enFlow device, a fluid warming system that brings the warming element closer to the patient, reducing heat loss and post-operative infections. The enFlow device will be introduced to market in November, and provides the company with an entry into what it claims is a $40-45m domestic market. Enginivity (Lexington, Massachusetts) sold its FDA-cleared and CE-marked products to hospitals and the US government but received no revenue in 2006.